The rising interest in GLP-1 medications for diabetes has led to a question about delivery routes : transdermal systems versus pills . Typically, GLP-1 treatments were exclusively available in pill form, but the introduction of patches provides a different choice . Skin applications might be advantageous for individuals with issues with oral medica